Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10 CAD | -1.48% |
|
-0.30% | +8.46% |
17/05 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
17/05 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.46% | 84.68M | |
+55.35% | 815B | |
+32.19% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.17% | 247B | |
+14.09% | 228B | |
+16.54% | 180B | |
+4.31% | 170B |
- Stock Market
- Equities
- RX Stock
- News BioSyent Inc.
- Transcript : BioSyent Inc., Q2 2022 Pre Recorded Earnings Call, Aug 23, 2022